These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 22626929

  • 1. Novel AAV-based genetic vaccines encoding truncated dengue virus envelope proteins elicit humoral immune responses in mice.
    Li X, Cao H, Wang Q, Di B, Wang M, Lu J, Pan L, Yang L, Mei M, Pan X, Li G, Wang L.
    Microbes Infect; 2012 Sep; 14(11):1000-7. PubMed ID: 22626929
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
    Khanam S, Pilankatta R, Khanna N, Swaminathan S.
    Vaccine; 2009 Oct 09; 27(43):6011-21. PubMed ID: 19665609
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen.
    Apt D, Raviprakash K, Brinkman A, Semyonov A, Yang S, Skinner C, Diehl L, Lyons R, Porter K, Punnonen J.
    Vaccine; 2006 Jan 16; 24(3):335-44. PubMed ID: 16125280
    [Abstract] [Full Text] [Related]

  • 6. Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors.
    Khanam S, Khanna N, Swaminathan S.
    Vaccine; 2006 Oct 30; 24(42-43):6513-25. PubMed ID: 16860446
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.
    Sjatha F, Kuwahara M, Sudiro TM, Kameoka M, Konishi E.
    Microbiol Immunol; 2014 Feb 30; 58(2):126-34. PubMed ID: 24372832
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice.
    Kochel T, Wu SJ, Raviprakash K, Hobart P, Hoffman S, Porter K, Hayes C.
    Vaccine; 1997 Apr 30; 15(5):547-52. PubMed ID: 9160523
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of immunity and protective efficacy of a dengue-3 pre-membrane and envelope DNA vaccine in Aotus nancymae monkeys.
    Blair PJ, Kochel TJ, Raviprakash K, Guevara C, Salazar M, Wu SJ, Olson JG, Porter KR.
    Vaccine; 2006 Feb 27; 24(9):1427-32. PubMed ID: 16214271
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein.
    Raviprakash K, Kochel TJ, Ewing D, Simmons M, Phillips I, Hayes CG, Porter KR.
    Vaccine; 2000 May 08; 18(22):2426-34. PubMed ID: 10738100
    [Abstract] [Full Text] [Related]

  • 12. DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.
    Mellado-Sánchez G, García-Cordero J, Luria-Pérez R, Lázaro-Olan L, Santos-Argumedo L, Gutiérrez-Castañeda B, Estrada-García I, Cedillo-Barrón L.
    Viral Immunol; 2005 May 08; 18(4):709-21. PubMed ID: 16359237
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection.
    Zheng Q, Fan D, Gao N, Chen H, Wang J, Ming Y, Li J, An J.
    Vaccine; 2011 Jan 17; 29(4):763-71. PubMed ID: 21095256
    [Abstract] [Full Text] [Related]

  • 15. A Novel Adeno-Associated Virus-Based Genetic Vaccine Encoding the Hepatitis C Virus NS3/4 Protein Exhibits Immunogenic Properties in Mice Superior to Those of an NS3-Protein-Based Vaccine.
    Zhu F, Chen T, Zhang Y, Sun H, Cao H, Lu J, Zhao L, Li G.
    PLoS One; 2015 Jan 17; 10(11):e0142349. PubMed ID: 26556235
    [Abstract] [Full Text] [Related]

  • 16. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.
    Putnak R, Fuller J, VanderZanden L, Innis BL, Vaughn DW.
    Am J Trop Med Hyg; 2003 Apr 17; 68(4):469-76. PubMed ID: 12875299
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties.
    Liu Y, Zhou J, Yu Z, Fang D, Fu C, Zhu X, He Z, Yan H, Jiang L.
    BMC Microbiol; 2014 Dec 18; 14():233. PubMed ID: 25520151
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity of a Candidate DNA Vaccine Based on the prM/E Genes of a Dengue Type 2 Virus Cosmopolitan Genotype Strain.
    Putri DH, Sudiro TM, Yunita R, Jaya UA, Dewi BE, Sjatha F, Konishi E, Hotta H, Sudarmono P.
    Jpn J Infect Dis; 2015 Dec 18; 68(5):357-63. PubMed ID: 25766602
    [Abstract] [Full Text] [Related]

  • 20. Induction of tetravalent protective immunity against four dengue serotypes by the tandem domain III of the envelope protein.
    Chen S, Yu M, Jiang T, Deng Y, Qin C, Qin E.
    DNA Cell Biol; 2007 Jun 18; 26(6):361-7. PubMed ID: 17570760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.